SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/14/16 Consonance Capital Management LP 13F-HR 9/30/16 2:13K Adv Consultant Netw… Inc |
Document/Exhibit Description Pages Size 1: 13F-HR Quarterly Holdings and Combination Report by a HTML 3K Money Manager -- primary_doc.xml 2: INFO-TABLE Description for Information Table -- HTML 3K form13fInfoTable.xml
Consonance Capital Management LP
| NY | |
Security | Market Valueª | Shares or Principal | Investment Discretion | Other Managersº | Voting Authority | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Issuer Name | Issue Class | Opt. | CUSIP/CINS | $1000s | Weight | Amount | S/P | Price | Sole | Shared | None | ||
↓List | (S/P Amounts or For All) | ||||||||||||
ADMA BIOLOGICS INC | COM | – | 000899·10·4 | 9,223 | 0.89% | 1,273,933 | Sh. | 7.24 | Sole | – | Sole | – | – |
AKORN INC | COM | – | 009728·10·6 | 59,972 | 5.77% | 2,200,000 | Sh. | 27.26 | Sole | – | Sole | – | – |
AMARIN CORP PLC | SPONS ADR NEW | – | 023111·20·6 | 78,641 | 7.57% | 24,652,380 | Sh. | 3.19 | Sole | – | Sole | – | – |
ANI PHARMACEUTICALS INC | COM | – | 00182C·10·3 | 43,344 | 4.17% | 653,258 | Sh. | 66.35 | Sole | – | Sole | – | – |
ARIAD PHARMACEUTICALS INC | COM | – | 04033A·10·0 | 119,045 | 11.46% | 8,695,742 | Sh. | 13.69 | Sole | – | Sole | – | – |
ATRICURE INC | COM | – | 04963C·20·9 | 3,667 | 0.35% | 231,926 | Sh. | 15.81 | Sole | – | Sole | – | – |
BIOLASE INC | COM | – | 090911·10·8 | 3,134 | 0.30% | 1,790,992 | Sh. | 1.75 | Sole | – | Sole | – | – |
CLOVIS ONCOLOGY INC | COM | – | 189464·10·0 | 127,310 | 12.25% | 3,531,487 | Sh. | 36.05 | Sole | – | Sole | – | – |
EHEALTH INC | COM | – | 28238P·10·9 | 12,944 | 1.25% | 1,154,711 | Sh. | 11.21 | Sole | – | Sole | – | – |
GLOBUS MED INC | CL A | – | 379577·20·8 | 41,980 | 4.04% | 1,860,000 | Sh. | 22.57 | Sole | – | Sole | – | – |
HEALTHSTREAM INC | COM | – | 42222N·10·3 | 9,407 | 0.91% | 340,847 | Sh. | 27.60 | Sole | – | Sole | – | – |
HORIZON PHARMA PLC | SHS | – | G4617B·10·5 | 67,061 | 6.45% | 3,698,903 | Sh. | 18.13 | Sole | – | Sole | – | – |
IRONWOOD PHARMACEUTICALS INC | COM CL A | – | 46333X·10·8 | 52,349 | 5.04% | 3,296,539 | Sh. | 15.88 | Sole | – | Sole | – | – |
MALLINCKRODT PUB LTD CO | SHS | – | G5785G·10·7 | 108,837 | 10.48% | 1,560,157 | Sh. | 69.76 | Sole | – | Sole | – | – |
MEDNAX INC | COM | – | 58502B·10·6 | 43,725 | 4.21% | 660,000 | Sh. | 66.25 | Sole | – | Sole | – | – |
MERRIMACK PHARMACEUTICALS IN | COM | – | 590328·10·0 | 37,784 | 3.64% | 5,950,225 | Sh. | 6.35 | Sole | – | Sole | – | – |
MYRIAD GENETICS INC | COM | – | 62855J·10·4 | 17,485 | 1.68% | 850,000 | Sh. | 20.57 | Sole | – | Sole | – | – |
ORTHOFIX INTL N V | COM | – | N6748L·10·2 | 27,137 | 2.61% | 634,496 | Sh. | 42.77 | Sole | – | Sole | – | – |
RETROPHIN INC | COM | – | 761299·10·6 | 69,041 | 6.65% | 3,084,947 | Sh. | 22.38 | Sole | – | Sole | – | – |
SEASPINE HLDGS CORP | COM | – | 81255T·10·8 | 2,658 | 0.26% | 262,934 | Sh. | 10.11 | Sole | – | Sole | – | – |
UNITED THERAPEUTICS CORP DEL | COM | – | 91307C·10·2 | 96,672 | 9.30% | 818,700 | Sh. | 118.08 | Sole | – | Sole | – | – |
VERACYTE INC | COM | – | 92337F·10·7 | 1,262 | 0.12% | 165,825 | Sh. | 7.61 | Sole | – | Sole | – | – |
VERICEL CORP | COM | – | 92346J·10·8 | 6,252 | 0.60% | 2,232,940 | Sh. | 2.80 | Sole | – | Sole | – | – |
— 23 Issuers — | — 23 Issues — | — 23 Holdings: $1,038,930,000 — | — Sole Manager — | ||||||||||
____________ ª No market value of any Holding was adjusted. º Other Included Managers with whom investment discretion is shared as to any Holding: No Other Included Managers |